Literature DB >> 23143465

CD44 expression in intraoral salivary ductal papillomas and oral papillary squamous cell carcinoma.

Sarah G Fitzpatrick1, Lindsay J Montague, Donald M Cohen, Indraneel Bhattacharyya.   

Abstract

CD44 is a transmembrane adhesion molecule which has been previously shown to be useful in the differentiation of benign papillary lesions from invasive carcinoma in several different areas including sinonasal mucosa and breast tissue. CD44 expression has previously been shown to be lost in invasive carcinoma and retained in benign papillary lesions in both of the above locations. In addition, studies have evaluated oral mucosal lesions for CD44 expression and found a loss with invasive squamous cell carcinoma when compared to normal epithelium, hyperplasia, and squamous papillomas, which stained particularly strongly. To the best of our knowledge, no study has evaluated CD44 expression when comparing salivary ductal papillomas in comparison to oral papillary SCCA. In this study 18 cases of intraductal papilloma were compared to 19 cases of oral papillary SCCA. Within the ductal papilloma group, all cases stained either absent (6%), weakly (33%), or moderately (61%) with 76% expressing the stain diffusely and 24% focally. In comparison, the papillary squamous cell carcinoma cases expressed the CD44 moderately (26%) or strongly (74%) with 100 % showing diffuse staining. Thus, the CD44 expression was contrary to expectation based on previous studies, which we hypothesize is due to the extremely well differentiated nature of papillary SCCA which expressed CD44 staining compatible with levels previously reported with oral squamous papillomas than invasive carcinoma.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23143465      PMCID: PMC3642258          DOI: 10.1007/s12105-012-0407-y

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  31 in total

1.  Sialadenoma papilliferum of the hard palate: report of 2 cases and immunohistochemical evaluation.

Authors:  M A Ubaidat; R A Robinson; P J Belding; D J Merryman
Journal:  Arch Pathol Lab Med       Date:  2001-12       Impact factor: 5.534

2.  Papillary squamous cell carcinoma of the head and neck: a clinicopathologic series.

Authors:  Jonathon O Russell; Aaron P Hoschar; Joseph Scharpf
Journal:  Am J Otolaryngol       Date:  2010-10-29       Impact factor: 1.808

3.  Discriminatory immunohistochemical staining of urothelial carcinoma in situ and non-neoplastic urothelium: an analysis of cytokeratin 20, p53, and CD44 antigens.

Authors:  J K McKenney; S Desai; C Cohen; M B Amin
Journal:  Am J Surg Pathol       Date:  2001-08       Impact factor: 6.394

4.  CD44 isoforms are differentially regulated in plasma cell dyscrasias and CD44v9 represents a new independent prognostic parameter in multiple myeloma.

Authors:  W Eisterer; O Bechter; W Hilbe; M van Driel; H M Lokhorst; J Thaler; A C Bloem; U Günthert; R Stauder
Journal:  Leuk Res       Date:  2001-12       Impact factor: 3.156

5.  Expression and prognostic value of CD44 standard and variant v3 and v6 isoforms in prostate cancer.

Authors:  S Aaltomaa; P Lipponen; M Ala-Opas; V M Kosma
Journal:  Eur Urol       Date:  2001-02       Impact factor: 20.096

Review 6.  Papillary squamous cell carcinoma of the larynx.

Authors:  Candice Colby; Adam M Klein
Journal:  Ear Nose Throat J       Date:  2011-08       Impact factor: 1.697

Review 7.  Ductal papillomas of salivary gland origin: A report of 19 cases and a review of the literature.

Authors:  R B Brannon; J J Sciubba; M Giulani
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2001-07

8.  CD44s as a surrogate marker for distinguishing intraductal papilloma from papillary carcinoma of the breast.

Authors:  M Saddik; R Lai
Journal:  J Clin Pathol       Date:  1999-11       Impact factor: 3.411

9.  Papillary squamous cell carcinomas of the upper aerodigestive tract: a clinicopathologic and molecular study.

Authors:  P A Suarez; K Adler-Storthz; M A Luna; A K El-Naggar; F W Abdul-Karim; J G Batsakis
Journal:  Head Neck       Date:  2000-07       Impact factor: 3.147

10.  A CD44⁻/CD24⁺ phenotype is a poor prognostic marker in early invasive breast cancer.

Authors:  Mohamed A H Ahmed; Mohammed A Aleskandarany; Emad A Rakha; Radwa Z A Moustafa; Ahmed Benhasouna; Christopher Nolan; Andrew R Green; Mohammad Ilyas; Ian O Ellis
Journal:  Breast Cancer Res Treat       Date:  2011-11-27       Impact factor: 4.872

View more
  2 in total

1.  Genetic analysis of radiation-specific biomarkers in sinonasal squamous cell carcinomas.

Authors:  Li Yan; Cheng Zhan; Shengzi Wang; Shuyi Wang; Luo Guo
Journal:  Tumour Biol       Date:  2016-05-10

2.  Expression of cell adhesion molecule CD44 in mucoepidermoid carcinoma and its association with the tumor behavior.

Authors:  Nada Binmadi; Azza Elsissi; Nadia Elsissi
Journal:  Head Face Med       Date:  2016-01-29       Impact factor: 2.151

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.